Positive News SentimentPositive News Semler Scientific Stock Price, News & Analysis (NASDAQ:SMLR) $40.30 +1.76 (+4.57%) (As of 12/1/2023 ET) Add Compare Share Share Today's Range$38.51▼$40.3150-Day Range$25.37▼$40.3052-Week Range$19.12▼$43.38Volume85,159 shsAverage Volume47,067 shsMarket Capitalization$276.86 millionP/E Ratio16.12Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Semler Scientific MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy3.91% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.81Based on 2 Articles This WeekInsider TradingAcquiring Shares$1.43 M Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.33 out of 5 starsMedical Sector274th out of 957 stocksElectromedical Equipment Industry6th out of 23 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Semler Scientific. Previous Next 3.0 Short Interest Percentage of Shares Shorted3.91% of the float of Semler Scientific has been sold short.Short Interest Ratio / Days to CoverSemler Scientific has a short interest ratio ("days to cover") of 4.1.Change versus previous monthShort interest in Semler Scientific has recently decreased by 3.68%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldSemler Scientific does not currently pay a dividend.Dividend GrowthSemler Scientific does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SMLR. Previous Next 4.3 News and Social Media Coverage News SentimentSemler Scientific has a news sentiment score of 1.81. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.77 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Semler Scientific this week, compared to 1 article on an average week.Search Interest11 people have searched for SMLR on MarketBeat in the last 30 days. This is an increase of 450% compared to the previous 30 days.MarketBeat Follows5 people have added Semler Scientific to their MarketBeat watchlist in the last 30 days. This is an increase of 400% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Semler Scientific insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,429,759.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders13.00% of the stock of Semler Scientific is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions93.60% of the stock of Semler Scientific is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Semler Scientific is 16.12, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 106.08.Price to Earnings Ratio vs. SectorThe P/E ratio of Semler Scientific is 16.12, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 88.36.Price to Book Value per Share RatioSemler Scientific has a P/B Ratio of 3.91. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Semler Scientific Stock (NASDAQ:SMLR)Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups, long-term care, or remote patient monitoring organizations. It offers its products through salespersons and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.Read More SMLR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SMLR Stock News HeadlinesDecember 2, 2023 | finance.yahoo.comA Look At The Intrinsic Value Of Semler Scientific, Inc. (NASDAQ:SMLR)November 18, 2023 | finance.yahoo.comSemler Scientific, Inc.'s (NASDAQ:SMLR) high institutional ownership speaks for itself as stock continues to impress, up 22% over last weekDecember 3, 2023 | Wealthpress (Ad)Trading Experts Call It “The Perfect Tesla Trade”Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.November 11, 2023 | finance.yahoo.comSemler Scientific, Inc. (NASDAQ:SMLR) Q3 2023 Earnings Call TranscriptNovember 9, 2023 | benzinga.comSemler Scientific: Q3 Earnings InsightsNovember 9, 2023 | finance.yahoo.comSemler Scientific Reports Third Quarter and Year-to-Date 2023 Financial ResultsNovember 1, 2023 | finance.yahoo.comInvestors in Semler Scientific (NASDAQ:SMLR) have unfortunately lost 51% over the last three yearsOctober 26, 2023 | finance.yahoo.comSemler Scientific to Report Third Quarter and First Nine Months of 2023 Financial Results and Host Conference Call on November 9, 2023December 3, 2023 | Wealthpress (Ad)Trading Experts Call It “The Perfect Tesla Trade”Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.October 12, 2023 | finance.yahoo.comIs Semler Scientific, Inc.'s (NASDAQ:SMLR) Latest Stock Performance A Reflection Of Its Financial Health?September 26, 2023 | msn.comSemler Scientific: The Business Is So Stellar That I'm Willing To Overlook Yellow FlagsSeptember 16, 2023 | msn.comSemler Scientific director buys 77,771 sharesSeptember 14, 2023 | finance.yahoo.comDirector Eric Semler Buys 77,771 Shares of Semler Scientific Inc (SMLR)August 31, 2023 | finance.yahoo.comSemler Scientific to Present at Upcoming Investor ConferenceAugust 11, 2023 | finanznachrichten.deSemler Scientific, Inc.: Semler Scientific Reports Second Quarter and First Half of 2023 Financial ResultsAugust 10, 2023 | finance.yahoo.comSemler Scientific Reports Second Quarter and First Half of 2023 Financial ResultsJuly 28, 2023 | seekingalpha.comSemler Scientific: A High-Quality, Cash Rich MicrocapJuly 28, 2023 | finance.yahoo.comSemler to Report Second Quarter 2023 Financial Results and Host Conference Call on August 10, 2023July 11, 2023 | msn.comSemler Scientific to achieve record Q2 revenue, reduces headcount, appoints CFOJuly 11, 2023 | markets.businessinsider.comSemler Scientific Projects Highest Quarterly Revenues In Q2; To Cut Headcount By Approx. 30%July 11, 2023 | finance.yahoo.comSemler Scientific Announces Appointment of Chief Financial Officer, Record Quarterly Revenues and Strategic StreamliningJune 23, 2023 | msn.comSemler Scientific to join Russell indexesJune 23, 2023 | finance.yahoo.comSemler Scientific to Join the Russell 2000® and 3000® IndexesMay 29, 2023 | finance.yahoo.comWith 45% ownership, Semler Scientific, Inc. (NASDAQ:SMLR) has piqued the interest of institutional investorsMay 11, 2023 | finanznachrichten.deSemler Scientific, Inc.: Semler Scientific Reports First Quarter 2023 Financial ResultsMay 10, 2023 | msn.comSemler Scientific: Q1 Earnings InsightsMay 10, 2023 | finance.yahoo.comSemler Scientific Reports First Quarter 2023 Financial ResultsSee More Headlines Receive SMLR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Semler Scientific and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/09/2023Today12/03/2023Fiscal Year End12/31/2023Next Earnings (Estimated)3/19/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SMLR CUSIPN/A CIK1554859 Webwww.semlerscientific.com Phone877-774-4211FaxN/AEmployees127Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$2.50 Trailing P/E Ratio16.12 Forward P/E RatioN/A P/E GrowthN/ANet Income$14.32 million Net Margins29.25% Pretax Margin37.72% Return on Equity30.96% Return on Assets27.20% Debt Debt-to-Equity RatioN/A Current Ratio7.51 Quick Ratio7.45 Sales & Book Value Annual Sales$56.69 million Price / Sales4.88 Cash Flow$2.18 per share Price / Cash Flow18.48 Book Value$10.30 per share Price / Book3.91Miscellaneous Outstanding Shares6,870,000Free Float5,980,000Market Cap$276.86 million OptionableNot Optionable Beta0.78 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesDr. Douglas Murphy-Chutorian M.D. (Age 69)Interim CEO, President & Director Comp: $870.46kDr. Herbert J. Semler (Age 95)Founder & Chairman Emeritus Comp: $41.25kMs. Renae Cormier (Age 51)CFO, Principal Accounting Officer, Head of Corp. Communications & Bus. Strategy and Secretary Ms. Jennifer Oliva HerringtonChief Operating OfficerMr. Shane ReidChief Technology OfficerMs. Cindy GuinassoSenior Vice President of Business DevelopmentMore ExecutivesKey CompetitorsAxoGenNASDAQ:AXGNOutset MedicalNASDAQ:OMZynexNASDAQ:ZYXIEdap TmsNASDAQ:EDAPFONARNASDAQ:FONRView All CompetitorsInsiders & InstitutionsWalleye Capital LLCSold 18,131 shares on 11/21/2023Ownership: 1.146%Jacobs Levy Equity Management Inc.Bought 4,261 shares on 11/17/2023Ownership: 1.013%Ameriprise Financial Inc.Sold 312 shares on 11/15/2023Ownership: 0.511%Qube Research & Technologies LtdBought 4,781 shares on 11/14/2023Ownership: 0.070%California State Teachers Retirement SystemSold 560 shares on 11/14/2023Ownership: 0.016%View All Insider TransactionsView All Institutional Transactions SMLR Stock Analysis - Frequently Asked Questions How have SMLR shares performed in 2023? Semler Scientific's stock was trading at $33.00 at the beginning of the year. Since then, SMLR shares have increased by 22.1% and is now trading at $40.30. View the best growth stocks for 2023 here. When is Semler Scientific's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 19th 2024. View our SMLR earnings forecast. How were Semler Scientific's earnings last quarter? Semler Scientific, Inc. (NASDAQ:SMLR) announced its quarterly earnings data on Thursday, November, 9th. The company reported $0.71 earnings per share (EPS) for the quarter. The company had revenue of $16.32 million for the quarter. Semler Scientific had a net margin of 29.25% and a trailing twelve-month return on equity of 30.96%. Who are Semler Scientific's major shareholders? Semler Scientific's stock is owned by a number of institutional and retail investors. Top institutional shareholders include LSV Asset Management (2.10%), Acadian Asset Management LLC (1.17%), Walleye Capital LLC (1.15%), Jacobs Levy Equity Management Inc. (1.01%), Northern Trust Corp (0.79%) and Charles Schwab Investment Management Inc. (0.57%). Insiders that own company stock include Douglas Murphy-Chutorian, Eric Semler, HC Chang & Diana Sho William and Wayne T Pan. View institutional ownership trends. How do I buy shares of Semler Scientific? Shares of SMLR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:SMLR) was last updated on 12/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Semler Scientific, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.